As many as seven districts in Assam, home to nearly 2 lakh people, have been affected by the first wave of flash floods that has hit the state this year. The Assam State Disaster Management Authority's (ASDMA) latest flood report notes that Nalbari and Tinsukia have joined the list of the flood-affected districts in the state.
Meanwhile, the Brahmaputra river in the state is already flowing above danger level at Neamatighat near Jorhat, with the water level in the river rising by the hour. As per a report by The Sentinel, the river is inching close to the 'danger level' at Guwahati, one of the key urban centres in the state. The Central Water Commission has already sounded the alarm for severe flood situation across four districts in Assam.
It had earlier been reported that parts of Lakhimpur, Dhemaji, Dibrugarh, Darrang and Goalpara districts in Assam are reeling under the latest floods that have added to the state's miseries, amid the ongoing COVID-19 pandemic crisis.
The ASDMA notes that rescue operations by the State Disaster Response Force (SDRF) and National Disaster Response Force (NDRF) are already underway in the affected parts.
The Regional Meteorological Centre (RMC) in Guwahati, the regional wing of the India Meteorological Department (IMD), has predicted heavy to very heavy rainfall across parts of the country's northeastern states.
Frequently Asked Questions
A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.
There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.
Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.